Powernet targets RM1bil order book in 6 months

kUALA LUMPUR: Kumpulan Powernet Bhd is targeting to increase its order book to RM1bil in six months after securing its first major project under the new management led by businessman Datuk Mohd Abdul Karim Abdullah

K Powernet bags RM254m construction job from Signvest

KUALA LUMPUR: Kumpulan Powernet Bhd has secured a RM254.32mil contract from Signvest Sdn Bhd to construct a 12-storey buiding here which also includes the completion of sewerage treatment facilities.

Taliworks 3Q net profit surges to RM72.6m

KUALA LUMPUR: Infrastructure company Taliworks Corporation Bhd posted a stronger set of earnings in the third quarter ended Sept 30,2019 with its net profit surging to RM72.63mil from RM19.68mil a year ago.

Ranhill eyes West Java project opportunities with local partner

KUALA LUMPUR: Ranhill Holdings Bhd expanded its regional prospects with the signing of three Memorandums of Understanding (MoU) with Indonesia’s PT Jasa Sarana.

AirAsia Group registers a loss in 3Q on new accounting treatment

KUALA LUMPUR: AirAsia Group Bhd made a loss in the third quarter ended Sept 30, as higher revenue achieved was offset by hefty accounting charges on its aircrafts and fuel hedge, as well as currency exchange losses.

Petronas Q3 profit halves on lower oil and gas prices

KUALA LUMPUR: Petroliam Nasional Bhd (Petronas) said global economic weakness amid rising geopolitical tensions and on-going trade war issues has impacted demand, as the national energy company reported a 52% drop in third quarter pre-tax profit.

Novartis to buy The Medicines Co for US$9.7bil

ZURICH: Novartis AG is buying US biotechnology company The Medicines Co for about US$9.7bil, the Swiss drugmaker said, as it seeks to expand its portfolio of medicines against cardiovascular disease.

CIMB team ups with Sun Life to offer medical plan

KUALA LUMPUR: CIMB Bank Bhd and insurance firm Sun Life Malaysia, which have collaborated to launch the Sun Prestige Health (SPH) medical plan, see more demand for such products, especially in times of economic uncertainty.

Novartis to buy Medicines Co. in US$6.8b deal for key drug

LONDON: Novartis AG agreed to buy Medicines Co. for about $6.8 billion, snapping up a promising cholesterol drug and adding to a string of recent acquisitions for Chief Executive Officer Vas Narasimhan.

PETALING JAYA: Asset management and infrastructure solutions company UEM Edgenta Bhd registered a net profit of RM17.28mil for the third quarter ended Sept 30, 2019.